Additionally, ILF2 has been reported to be highly expressed in ESCC and suggested to be a prognostic factor for the poor outcome of ESCC patients (Ni S. et al., 2015; Wen-Jian et al., 2019). This evidence concerns the gene ILF2 and esophageal squamous cell carcinoma.